← Back to Search

Behavioral Intervention

PN+mHealth for Opioid Use Disorder (MIAPP Trial)

N/A
Recruiting
Led By Judith I Tsui, MD, MPH
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 90 days post-discharge from hospital
Awards & highlights

MIAPP Trial Summary

This trial aims to test a new program called "MHealth Incentivized Adherence Plus Patient Navigation" (MIAPP) to help patients with opioid and methamphetamine use disorders who are hospitalized.

Who is the study for?
This trial is for adults over 18 who are hospitalized at Harborview Medical Center, have used methamphetamine in the last 30 days, and started or plan to continue buprenorphine treatment for opioid use disorder after discharge. Participants must be willing to use a smartphone and work with a patient navigator.Check my eligibility
What is being tested?
The study tests 'MHealth Incentivized Adherence Plus Patient Navigation' (MIAPP) combined with usual care versus usual care alone. It aims to improve linkage to outpatient treatment and retention on medication for opioid use disorder among patients also using methamphetamine.See study design
What are the potential side effects?
While specific side effects are not detailed here, typical concerns may include issues related to the management of opioid use disorder and potential interactions or challenges with technology-based interventions.

MIAPP Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~90 days post-discharge from hospital
This trial's timeline: 3 weeks for screening, Varies for treatment, and 90 days post-discharge from hospital for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Patient linkage to an outpatient program that provides medication for opioid use disorder
Secondary outcome measures
Emergency department visits
Hospital readmission
Past 30-day methamphetamine use
+2 more

MIAPP Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: PN+mHealthExperimental Treatment1 Intervention
The intervention is patient navigation and mHealth in addition to treatment-as-usual. The intervention consists of a patient navigator (PN) with the mHealth adherence application facilitating telehealth visits, two-way chats, video-DOT, and delivery of financial incentives via smartphone for adherence and linkage to outpatient treatment within 30 days. Participants will be asked to upload medication adherence videos once a day over the 30 days post discharge from the hospital. Patients will be instructed to continue to take their medication as prescribed in any circumstance where they are unable to upload the video for any reason.
Group II: Treatment-as-usual (TAU)Active Control1 Intervention
TAU will be usual care that the Addiction Consult Service provides. It is comprised of a multidisciplinary team of professionals, including addiction medicine and addiction psychiatry physicians, nurses specializing in the treatment of OUD, substance use disorder counselors, peer recovery supports, and program coordinators.

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,741 Previous Clinical Trials
1,847,720 Total Patients Enrolled
National Institute on Drug Abuse (NIDA)NIH
2,470 Previous Clinical Trials
2,619,691 Total Patients Enrolled
Judith I Tsui, MD, MPHPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
40 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there currently any available slots for new participants in this medical trial?

"As per clinicaltrials.gov, patient recruitment is ongoing for this current trial. The initial posting of the study was on 1/3/2024 and the latest update occurred on 3/21/2024."

Answered by AI
Recent research and studies
clinicaltrials.govStudy
MHealth Incentivized Adherence Plus Patient Navigation
Judith I. Tsui 2024. "MHealth Incentivized Adherence Plus Patient Navigation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06027814.
~27 spots leftby Nov 2024
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top